ITA3221
ITA3221
ITA3221
from
$526.00
Price in reward points: 526
- Catalog: ITA3221
- Gene/Protein: USP37
- Product Description: Immunotag™ USP37 Antibody
-
Description
-
Specifications
Antibody Specification Datasheet 
IMPORTANT NOTE This product is custom manufactured with a lead time of 3-4 weeks. Once in production, this item cannot be cancelled from an order and is not eligible for return. Target Protein USP37 Clonality Polyclonal Storage/Stability -20°C/1 year Application WB,IHC,ELISA Recommended Dilution WB 1:500-1:2000 IHC 1:50-1:200 Concentration 1 mg/ml Reactive Species Human,Rat Host Species Rabbit Immunogen A synthesized peptide Specificity USP37 antibody detects endogenous levels of total USP37 Purification The antiserum was purified by peptide affinity chromatography. Form Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Gene Name USP37 Accession No. Q86T82 Alternate Names Deubiquitinating enzyme 3; Deubiquitinating enzyme 37; EC 3.1.2.15; KIAA1594; MGC117261; OTTHUMP00000164146; tmp_locus_50; Ubiquitin carboxyl-terminal hydrolase 37; Ubiquitin specific peptidase 37; Ubiquitin specific processing protease 37; Ubiquitin specific protease 37; Ubiquitin thioesterase 37; Ubiquitin thiolesterase 37; Ubiquitin-specific-processing protease 37; UBP37_HUMAN; USP37; Description Deubiquitinase that antagonizes the anaphase-promoting complex (APC/C) during G1/S transition by mediating deubiquitination of cyclin-A (CCNA1 and CCNA2), thereby promoting S phase entry. Specifically mediates deubiquitination of 'Lys-11'-linked polyubiquitin chains, a specific ubiquitin-linkage type mediated by the APC/C complex. Also mediates deubiquitination of 'Lys-48'-linked polyubiquitin chains in vitro. Phosphorylation at Ser-628 during G1/S phase maximizes the deubiquitinase activity, leading to prevent degradation of cyclin-A (CCNA1 and CCNA2) (PubMed:21596315). Plays an important role in the regulation of DNA replication by stabilizing the licensing factor CDT1 (PubMed:27296872). Cell Pathway/ Category Primary Polyclonal Antibody Protein MW 120 kDa Usage For Research Use Only! Not for diagnostic or therapeutic procedures. - Reviews
| Antibody Specification | |
| Datasheet |
|
| IMPORTANT NOTE | This product is custom manufactured with a lead time of 3-4 weeks. Once in production, this item cannot be cancelled from an order and is not eligible for return. |
| Target Protein | USP37 |
| Clonality | Polyclonal |
| Storage/Stability | -20°C/1 year |
| Application | WB,IHC,ELISA |
| Recommended Dilution | WB 1:500-1:2000 IHC 1:50-1:200 |
| Concentration | 1 mg/ml |
| Reactive Species | Human,Rat |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide |
| Specificity | USP37 antibody detects endogenous levels of total USP37 |
| Purification | The antiserum was purified by peptide affinity chromatography. |
| Form | Rabbit IgG in phosphate buffered saline, pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Gene Name | USP37 |
| Accession No. | Q86T82 |
| Alternate Names | Deubiquitinating enzyme 3; Deubiquitinating enzyme 37; EC 3.1.2.15; KIAA1594; MGC117261; OTTHUMP00000164146; tmp_locus_50; Ubiquitin carboxyl-terminal hydrolase 37; Ubiquitin specific peptidase 37; Ubiquitin specific processing protease 37; Ubiquitin specific protease 37; Ubiquitin thioesterase 37; Ubiquitin thiolesterase 37; Ubiquitin-specific-processing protease 37; UBP37_HUMAN; USP37; |
| Description | Deubiquitinase that antagonizes the anaphase-promoting complex (APC/C) during G1/S transition by mediating deubiquitination of cyclin-A (CCNA1 and CCNA2), thereby promoting S phase entry. Specifically mediates deubiquitination of 'Lys-11'-linked polyubiquitin chains, a specific ubiquitin-linkage type mediated by the APC/C complex. Also mediates deubiquitination of 'Lys-48'-linked polyubiquitin chains in vitro. Phosphorylation at Ser-628 during G1/S phase maximizes the deubiquitinase activity, leading to prevent degradation of cyclin-A (CCNA1 and CCNA2) (PubMed:21596315). Plays an important role in the regulation of DNA replication by stabilizing the licensing factor CDT1 (PubMed:27296872). |
| Cell Pathway/ Category | Primary Polyclonal Antibody |
| Protein MW | 120 kDa |
| Usage | For Research Use Only! Not for diagnostic or therapeutic procedures. |